High Vista Strategies LLC Nurix Therapeutics, Inc. Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$12.94 - $29.65 $243,220 - $557,301
-18,796 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$22.71 - $36.69 $240,362 - $388,326
-10,584 Reduced 36.02%
18,796 $563,000
Q2 2021

Aug 16, 2021
BUY
$24.21 - $35.89 $245,925 - $364,570
10,158 Added 52.85%
29,380 $779,000
Q1 2021

May 17, 2021
BUY
$26.98 - $50.17 $518,609 - $964,367
19,222 New
19,222 $598,000

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.04B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email